The study of VEGF-C tissue expression could be pivotal in carcinomas since they not only can augment lymphatic endothelial cell migration, proliferation, and survival (through VEGFR-3), but can also contribute the same in the vascular endothelium (through VEGFR2/R3 heterodimer). Here, VEGFC is linked to carcinoma.